RU2599033C2 - Гемостатическое устройство - Google Patents
Гемостатическое устройство Download PDFInfo
- Publication number
- RU2599033C2 RU2599033C2 RU2015101029/15A RU2015101029A RU2599033C2 RU 2599033 C2 RU2599033 C2 RU 2599033C2 RU 2015101029/15 A RU2015101029/15 A RU 2015101029/15A RU 2015101029 A RU2015101029 A RU 2015101029A RU 2599033 C2 RU2599033 C2 RU 2599033C2
- Authority
- RU
- Russia
- Prior art keywords
- hemostatic
- substrate
- binder
- sponge
- gauze
- Prior art date
Links
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 284
- 239000000463 material Substances 0.000 claims abstract description 262
- 239000000758 substrate Substances 0.000 claims abstract description 233
- 239000011230 binding agent Substances 0.000 claims abstract description 153
- 210000004369 blood Anatomy 0.000 claims abstract description 81
- 239000008280 blood Substances 0.000 claims abstract description 81
- 230000000740 bleeding effect Effects 0.000 claims abstract description 65
- 239000004927 clay Substances 0.000 claims abstract description 60
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000005995 Aluminium silicate Substances 0.000 claims abstract description 55
- 235000012211 aluminium silicate Nutrition 0.000 claims abstract description 55
- 235000010410 calcium alginate Nutrition 0.000 claims abstract description 42
- 239000000648 calcium alginate Substances 0.000 claims abstract description 42
- 229960002681 calcium alginate Drugs 0.000 claims abstract description 42
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims abstract description 41
- 239000011159 matrix material Substances 0.000 claims abstract description 39
- -1 gauze Substances 0.000 claims abstract description 35
- 230000015271 coagulation Effects 0.000 claims abstract description 12
- 238000005345 coagulation Methods 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 53
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 238000001035 drying Methods 0.000 claims description 35
- 239000006260 foam Substances 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 23
- 238000005507 spraying Methods 0.000 claims description 21
- 229920000642 polymer Polymers 0.000 claims description 17
- 229920000728 polyester Polymers 0.000 claims description 14
- 229920003023 plastic Polymers 0.000 claims description 7
- 239000004033 plastic Substances 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 229920000742 Cotton Polymers 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 229920000297 Rayon Polymers 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 239000004599 antimicrobial Substances 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229910052622 kaolinite Inorganic materials 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 5
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 4
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 229940035676 analgesics Drugs 0.000 claims description 4
- 239000000730 antalgic agent Substances 0.000 claims description 4
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 4
- 229940088710 antibiotic agent Drugs 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- 229940121375 antifungal agent Drugs 0.000 claims description 4
- 229940125715 antihistaminic agent Drugs 0.000 claims description 4
- 239000000739 antihistaminic agent Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229910001431 copper ion Inorganic materials 0.000 claims description 4
- 239000005015 poly(hydroxybutyrate) Substances 0.000 claims description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 4
- 239000004584 polyacrylic acid Substances 0.000 claims description 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052625 palygorskite Inorganic materials 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229960000892 attapulgite Drugs 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
- 210000002268 wool Anatomy 0.000 claims description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 239000000126 substance Substances 0.000 abstract description 26
- 239000000178 monomer Substances 0.000 abstract description 15
- 230000023555 blood coagulation Effects 0.000 abstract description 9
- 239000004744 fabric Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 abstract 1
- 229940014041 hyaluronate Drugs 0.000 abstract 1
- 239000002874 hemostatic agent Substances 0.000 description 136
- 206010052428 Wound Diseases 0.000 description 133
- 208000027418 Wounds and injury Diseases 0.000 description 133
- 229940030225 antihemorrhagics Drugs 0.000 description 132
- 229920000615 alginic acid Polymers 0.000 description 113
- 235000010443 alginic acid Nutrition 0.000 description 112
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 98
- 229940072056 alginate Drugs 0.000 description 97
- 238000000034 method Methods 0.000 description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 80
- 239000000725 suspension Substances 0.000 description 50
- 239000000835 fiber Substances 0.000 description 46
- 238000004132 cross linking Methods 0.000 description 39
- 239000000523 sample Substances 0.000 description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 30
- 239000011780 sodium chloride Substances 0.000 description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 21
- 235000010413 sodium alginate Nutrition 0.000 description 21
- 239000000661 sodium alginate Substances 0.000 description 21
- 229940005550 sodium alginate Drugs 0.000 description 21
- 230000008569 process Effects 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 239000011575 calcium Substances 0.000 description 19
- 239000002245 particle Substances 0.000 description 19
- 229910052791 calcium Inorganic materials 0.000 description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 17
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 239000001110 calcium chloride Substances 0.000 description 15
- 229910001628 calcium chloride Inorganic materials 0.000 description 15
- 235000011148 calcium chloride Nutrition 0.000 description 15
- 238000010521 absorption reaction Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 10
- 230000006835 compression Effects 0.000 description 10
- 238000007906 compression Methods 0.000 description 10
- 210000000416 exudates and transudate Anatomy 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 206010053567 Coagulopathies Diseases 0.000 description 9
- 230000035602 clotting Effects 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 238000004806 packaging method and process Methods 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 8
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 229960005150 glycerol Drugs 0.000 description 8
- 229920005862 polyol Polymers 0.000 description 8
- 150000003077 polyols Chemical class 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 229910001424 calcium ion Inorganic materials 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000003431 cross linking reagent Substances 0.000 description 7
- 239000011243 crosslinked material Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000007654 immersion Methods 0.000 description 7
- 230000004584 weight gain Effects 0.000 description 7
- 235000019786 weight gain Nutrition 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 150000001768 cations Chemical class 0.000 description 6
- 238000001125 extrusion Methods 0.000 description 6
- 239000002657 fibrous material Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229920001661 Chitosan Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002250 absorbent Substances 0.000 description 5
- 230000002745 absorbent Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 5
- 239000000428 dust Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 239000007791 liquid phase Substances 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 229910052615 phyllosilicate Inorganic materials 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000003352 sequestering agent Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- 239000003357 wound healing promoting agent Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000005909 Kieselgur Substances 0.000 description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 3
- 108090000190 Thrombin Proteins 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 3
- 229940099552 hyaluronan Drugs 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229910052645 tectosilicate Inorganic materials 0.000 description 3
- 229960004072 thrombin Drugs 0.000 description 3
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052604 silicate mineral Inorganic materials 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 230000009974 thixotropic effect Effects 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 238000010407 vacuum cleaning Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- CTBUVTVWLYTOGO-UWVJOHFNSA-N 2-[(11z)-11-[3-(dimethylamino)propylidene]-6h-benzo[c][1]benzoxepin-2-yl]acetaldehyde Chemical compound C1OC2=CC=C(CC=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 CTBUVTVWLYTOGO-UWVJOHFNSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010074864 Factor XI Proteins 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 102000000429 Factor XII Human genes 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241001082241 Lythrum hyssopifolia Species 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 241001595840 Margarites Species 0.000 description 1
- 238000012565 NMR experiment Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- HEHRHMRHPUNLIR-UHFFFAOYSA-N aluminum;hydroxy-[hydroxy(oxo)silyl]oxy-oxosilane;lithium Chemical compound [Li].[Al].O[Si](=O)O[Si](O)=O.O[Si](=O)O[Si](O)=O HEHRHMRHPUNLIR-UHFFFAOYSA-N 0.000 description 1
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229910052908 analcime Inorganic materials 0.000 description 1
- 229910052898 antigorite Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical class [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229910052620 chrysotile Inorganic materials 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910052607 cyclosilicate Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010433 feldspar Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 229910052631 glauconite Inorganic materials 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 229910052621 halloysite Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052900 illite Inorganic materials 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000009616 inductively coupled plasma Methods 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052610 inosilicate Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 229910052629 lepidolite Inorganic materials 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 229910052630 margarite Inorganic materials 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 229910052605 nesosilicate Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000004762 orthosilicates Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229910052670 petalite Inorganic materials 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 238000012667 polymer degradation Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960002244 promethazine hydrochloride Drugs 0.000 description 1
- XXPDBLUZJRXNNZ-UHFFFAOYSA-N promethazine hydrochloride Chemical compound Cl.C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 XXPDBLUZJRXNNZ-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229910052903 pyrophyllite Inorganic materials 0.000 description 1
- 229910052646 quartz group Inorganic materials 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229910052671 scapolite group Inorganic materials 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052616 serpentine group Inorganic materials 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229910052606 sorosilicate Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- CWBIFDGMOSWLRQ-UHFFFAOYSA-N trimagnesium;hydroxy(trioxido)silane;hydrate Chemical compound O.[Mg+2].[Mg+2].[Mg+2].O[Si]([O-])([O-])[O-].O[Si]([O-])([O-])[O-] CWBIFDGMOSWLRQ-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- UKRDPEFKFJNXQM-UHFFFAOYSA-N vinylsilane Chemical compound [SiH3]C=C UKRDPEFKFJNXQM-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000004017 vitrification Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052649 zeolite group Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/04—Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Massaging Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261663412P | 2012-06-22 | 2012-06-22 | |
| US61/663,412 | 2012-06-22 | ||
| US201361754129P | 2013-01-18 | 2013-01-18 | |
| US61/754,129 | 2013-01-18 | ||
| PCT/US2013/041659 WO2013191836A1 (en) | 2012-06-22 | 2013-05-17 | Hemostatic devices |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2015101029A RU2015101029A (ru) | 2016-08-10 |
| RU2599033C2 true RU2599033C2 (ru) | 2016-10-10 |
Family
ID=49769198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015101029/15A RU2599033C2 (ru) | 2012-06-22 | 2013-05-17 | Гемостатическое устройство |
Country Status (23)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2721281C1 (ru) * | 2019-07-29 | 2020-05-18 | Общество с ограниченной ответственностью "Нанотехнологии и инновации" | Фармацевтическая композиция, обладающая антимикробной и противогрибковой активностью |
| RU2793065C1 (ru) * | 2023-02-03 | 2023-03-28 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Ручное автономное устройство двухкомпонентной биопечати для лечения раневых поверхностей и способ нанесения покрытия на раневую поверхность ручным автономным устройством |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006214371A1 (en) | 2005-02-15 | 2006-08-24 | Virginia Commonwealth University | Mineral technologies (MT) for acute hemostasis and for the treatment of acute wounds and chronic ulcers |
| US8938898B2 (en) | 2006-04-27 | 2015-01-27 | Z-Medica, Llc | Devices for the identification of medical products |
| US7604819B2 (en) | 2006-05-26 | 2009-10-20 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US8858969B2 (en) | 2010-09-22 | 2014-10-14 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
| WO2013056116A1 (en) * | 2011-10-12 | 2013-04-18 | The Trustees Of Columbia University In The City Of New York | Hemostatic dressing for arterial bleeding |
| IN2014DN11041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2012-06-22 | 2015-09-25 | Z Medica Llc | |
| US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
| US9901366B2 (en) * | 2013-07-27 | 2018-02-27 | Lawrence A. Colby | Systems and methods for enhancing the visibility of medical items |
| US9943201B2 (en) * | 2014-05-27 | 2018-04-17 | Big Foot Suction, Llc | Floor suction device |
| CN104162182B (zh) * | 2014-08-06 | 2016-04-13 | 暨南大学 | 一种具有抗菌促愈合活性的复合止血粉及其制备方法 |
| CN104162183A (zh) * | 2014-08-06 | 2014-11-26 | 暨南大学 | 一种壳聚糖与埃洛石纳米管的复合止血粉及其制备方法 |
| TN2017000345A1 (en) * | 2015-02-16 | 2019-01-16 | Ihor Volodymyrovych Gaiovych | Hemostatic composition and hemostatic device (variants) |
| CA2980020C (en) | 2015-03-30 | 2023-08-01 | Giridhar Thiagarajan | Application of antimicrobial agents to medical devices |
| EP3389814B1 (en) * | 2015-12-16 | 2021-03-10 | Khalifa University of Science and Technology | Method of treating a liquid using calcium alginate adsorbents |
| CN105497966B (zh) * | 2015-12-28 | 2018-08-17 | 浙江科技学院 | 一种高稳定性高可吸收性的止血纱布产品的制备装置及其方法 |
| KR20170093536A (ko) * | 2016-02-05 | 2017-08-16 | 주식회사 유엔헬스케어 | 카올린 및 키토산을 유효성분으로 포함하는 지혈 붕대 |
| CN105920651A (zh) * | 2016-06-27 | 2016-09-07 | 江苏康博医疗器械有限公司 | 一种pva海绵功能敷料制作工艺及应用 |
| IL247786B (en) * | 2016-09-12 | 2019-08-29 | Plotkin Alexander | Covers the wound with a hemostatic action and method and creates it |
| WO2018079899A1 (ko) * | 2016-10-27 | 2018-05-03 | 주식회사 유엔헬스케어 | 건습식형 창상피복재의 제조방법 및 이에 의해 제조된 창상피복재 |
| WO2018080692A1 (en) * | 2016-10-27 | 2018-05-03 | El Sabahy Mahmoud Fahmy Ali | Nanotechnology-based hemostatic dressings |
| CN116919648A (zh) | 2016-11-03 | 2023-10-24 | 代表亚利桑那大学的亚利桑那董事会 | 有或无氧气输送的堆叠组织包封装置的系统 |
| WO2018085714A1 (en) | 2016-11-03 | 2018-05-11 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery |
| AU2017396754B2 (en) | 2016-11-03 | 2021-08-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation |
| CN108093553A (zh) * | 2016-11-21 | 2018-05-29 | 奇想创造事业股份有限公司 | 涂布电路元件的基材-发光材-电热敷料及包材 |
| EP3589333A1 (en) * | 2017-03-03 | 2020-01-08 | Loma Linda University Health | Compositions and methods for promoting hemostasis |
| JP2020517399A (ja) * | 2017-04-28 | 2020-06-18 | クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ | 活動性出血を伴う消化管病変のバイモーダル治療方法及び組成物 |
| CN107213508B (zh) * | 2017-06-09 | 2018-04-06 | 中南大学 | 一种含铁氧化物/纳米高岭土复合止血剂及其制备方法 |
| WO2019016367A1 (de) * | 2017-07-21 | 2019-01-24 | Speed Care Mineral Ug (Haftungsbeschränkt) | Neuartige wundauflage zur blutstillung |
| CN109381733A (zh) * | 2017-08-04 | 2019-02-26 | 天津工业大学 | 一种表面粗糙度可控的高岭土/海藻酸钙膜止血抗菌敷料的制备方法 |
| IL254644B (en) * | 2017-09-24 | 2021-06-30 | Reddress Ltd | Device for dressing a wound, system and method |
| CN107715165A (zh) * | 2017-09-30 | 2018-02-23 | 河南亚都实业有限公司 | 医用脱脂棉纱布及其加工设备 |
| CN109772450B (zh) * | 2017-11-10 | 2022-01-11 | 中国科学院大连化学物理研究所 | 一种碱性树脂负载纳米金催化剂及其制备和应用 |
| CN108079367A (zh) * | 2017-12-18 | 2018-05-29 | 广东省人民医院(广东省医学科学院) | 一种含有田七活性成分的海藻酸钙止血海绵及其制备方法和应用 |
| EP3817785A4 (en) | 2018-07-02 | 2022-07-20 | C. R. Bard, Inc. | Antimicrobial catheter assemblies and methods thereof |
| WO2020068814A1 (en) * | 2018-09-24 | 2020-04-02 | University Of Iowa Research Foundation | Ultra-light weight hemostatic microspheres |
| US20200100944A1 (en) * | 2018-10-02 | 2020-04-02 | Pfm Medical, Inc. | Interventional device dressing system |
| MX2021005161A (es) * | 2018-11-02 | 2021-10-13 | Covalon Tech Inc | Composiciones de espuma, matrices de espuma y metodos. |
| WO2020157633A2 (en) * | 2019-01-28 | 2020-08-06 | Core Scientific Creations Ltd. | Wound dressing compositions and methods |
| EP3930770B1 (de) * | 2019-02-28 | 2024-11-06 | Speed Care Mineral GmbH | Paste für die markierung von röntgenkontrastunfähigen wundauflagen |
| CN110152048A (zh) * | 2019-05-13 | 2019-08-23 | 浙江惠龙医疗科技股份有限公司 | 一种具有抗疤痕再生功能医用敷料及其制备方法 |
| CN111058189A (zh) * | 2019-12-12 | 2020-04-24 | 杭州诚品实业有限公司 | 一种负载有透明质酸的高保湿可降解竹纤维无纺布及其制备方法 |
| EP4082586B1 (en) * | 2019-12-26 | 2025-04-23 | Artisan Lab Co., Ltd. | Method for producing material for local hemostasis, and material for local hemostasis |
| KR102302405B1 (ko) | 2020-01-07 | 2021-09-16 | 주식회사 테라시온 바이오메디칼 | 마이크로-비드 및 그 제조방법, 이를 포함하는 지혈 드레싱의 제조방법 |
| US11559472B2 (en) * | 2020-07-22 | 2023-01-24 | Terry Suzuki | Bentonite and skin treatment combination method and packaging |
| IT202000019642A1 (it) | 2020-08-07 | 2022-02-07 | Gaetano Mauro | Erogatore di polvere emostatica ad aria compressa, dotato di cannula biocompatibile, da usare nel primo trattamento di ferite da arma da fuoco o da taglio |
| TWI776219B (zh) * | 2020-08-31 | 2022-09-01 | 財團法人塑膠工業技術發展中心 | 一種具梯度濃度結構之材料的配方、結構及其應用 |
| CA3196876A1 (en) | 2020-10-30 | 2022-05-05 | Klearchos Papas | Methods and systems for encapsulation devices for housing cells and agents |
| CN112402684A (zh) * | 2020-11-25 | 2021-02-26 | 联科华技术有限公司 | 一种单原子抗菌消毒止血纱布及其制备方法 |
| KR102260452B1 (ko) | 2020-12-08 | 2021-06-03 | 주식회사 멘티스로지텍 | 흡수성 체내용 지혈조성물의 제조방법 및 그에 따라 제조된 지혈조성물 |
| CN115025274B (zh) * | 2021-03-04 | 2023-03-17 | 海宁侏罗纪生物科技有限公司 | 一种医用组织粘合胶及其制备方法 |
| CN115252875B (zh) * | 2021-04-29 | 2023-06-16 | 浙江大学 | 一种医用组织粘合胶及其制备方法 |
| CN113209357B (zh) * | 2021-05-14 | 2023-02-17 | 南方科技大学 | 复合止血粉 |
| KR102685039B1 (ko) * | 2021-07-05 | 2024-07-18 | 주식회사 테라시온바이오메디칼 | 생체적합성 고분자를 포함하는 파우더형 지혈제 및 그의 제조방법 |
| WO2023031696A1 (en) * | 2021-09-01 | 2023-03-09 | 3M Innovative Properties Company | Nonwoven with bio particles and methods of making the same |
| CN113599573A (zh) * | 2021-09-07 | 2021-11-05 | 贵州医科大学 | 一种急救用形变记忆多孔水凝胶止血材料及其制备方法 |
| CN113908325B (zh) * | 2021-09-24 | 2023-01-17 | 中山大学 | 一种低黏附抗血液流失的止血材料及其制备方法和应用 |
| KR102458897B1 (ko) * | 2022-02-21 | 2022-10-27 | 대가파우더시스템 주식회사 | 지혈제가 내재된 지혈 유닛 |
| US20250213751A1 (en) * | 2022-04-04 | 2025-07-03 | The University Of North Carolina At Chapel Hill | Adaptive patches for dynamic organs |
| EP4545572A1 (en) * | 2022-06-24 | 2025-04-30 | Osaka University | Alginic acid salt and hemostatic material containing same |
| CN115300663A (zh) * | 2022-07-28 | 2022-11-08 | 贵州民族大学 | 一种止血复合膜及其制备方法 |
| CN115463242B (zh) * | 2022-09-27 | 2023-09-08 | 中国地质大学（武汉） | 一种高岭土止血纱布及其制备方法 |
| CN115721772B (zh) * | 2022-12-15 | 2024-05-10 | 湖南中腾湘岳生物科技有限公司 | 一种可吸收止血材料 |
| CN116036343B (zh) * | 2023-01-06 | 2024-06-21 | 杭州沸创生命科技股份有限公司 | 一种沸石止血纱布材料及其制备方法 |
| CN117159784B (zh) * | 2023-03-31 | 2024-04-19 | 鹏拓生物科技(杭州)有限公司 | 用于难愈性创面修复的液体创可贴及其制备方法和应用 |
| KR102621468B1 (ko) | 2023-10-31 | 2024-01-11 | 주식회사 멘티스 | 협동로봇 기반의 흡수성 체내용 지혈용품 생산 자동화 시스템 및 생산 자동화 방법 |
| CN117567790B (zh) * | 2024-01-15 | 2024-03-26 | 四川大学 | 内部促凝血外表面抗凝血的医用聚氨酯泡沫及其制备方法 |
| KR102743315B1 (ko) | 2024-06-25 | 2024-12-16 | 주식회사 이노파마 | 카올린과 셀룰로오스를 혼합한 분사형 지혈제 제조방법 및 그에 따라 제조된 분사형 지혈제 |
| KR102729703B1 (ko) | 2024-06-25 | 2024-11-13 | 주식회사 이노파마 | 카올린과 셀룰로오스를 혼합한 부착형 지혈제 제조방법 및 그에 따라 제조된 부착형 지혈제 |
| KR102743316B1 (ko) | 2024-06-25 | 2024-12-16 | 주식회사 이노파마 | 카올린과 셀룰로오스를 혼합한 분말 도포형 지혈제 제조방법 및 그에 따라 제조된 분말 도포형 지혈제 |
| CN118903513A (zh) * | 2024-07-16 | 2024-11-08 | 中国地质大学（武汉） | 一种纤维复合铝系矿物的高稳定性多功能止血纱布及其制备方法 |
| CN119868629B (zh) * | 2024-12-18 | 2025-08-29 | 四川大学 | 一种复合止血材料及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060141018A1 (en) * | 2001-12-31 | 2006-06-29 | Crosslink-D, Incorporated, A Delaware Corporation | Hemostatic compositions and methods for controlling bleeding |
| US20110237994A1 (en) * | 2010-03-25 | 2011-09-29 | Combat Medical Systems, Llc | Void-filling wound dressing |
| US20120130296A1 (en) * | 2006-05-26 | 2012-05-24 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
Family Cites Families (282)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB548046A (en) | 1941-02-19 | 1942-09-23 | Walter Sim Harris | Improvements in or relating to lint, bandages, gauze, cotton wool and other surgicaldressings and bindings |
| US2688586A (en) | 1950-03-17 | 1954-09-07 | Johnson & Johnson | Improved hemostatic alginic surgical dressings and method of making |
| US2969145A (en) | 1956-05-07 | 1961-01-24 | Johnson & Johnson | Packaged adhesive bandage |
| US2922719A (en) | 1957-04-08 | 1960-01-26 | Zonolite Company | Structural clay products and method of making the same |
| US3122140A (en) | 1962-03-29 | 1964-02-25 | Johnson & Johnson | Flexible absorbent sheet |
| US3189227A (en) | 1962-12-07 | 1965-06-15 | American Home Prod | Fluid dispenser |
| US3181231A (en) | 1963-08-06 | 1965-05-04 | Union Carbide Corp | Molecular sieve-metal agglomerates and their preparation |
| US3366578A (en) | 1964-12-07 | 1968-01-30 | Universal Oil Prod Co | Zeolite and method for making the improved zeolite |
| GB1155440A (en) | 1966-01-18 | 1969-06-18 | Herman Ferdinand Kamp | Therapeutic Composition for Treating Skin Injuries |
| US3550593A (en) | 1967-02-02 | 1970-12-29 | Jack W Kaufman | Therapeutic apparatus |
| US3386802A (en) | 1967-07-28 | 1968-06-04 | Universal Oil Prod Co | Method for preparing spherically-shaped crystalline zeolite particles |
| US3538508A (en) | 1968-08-08 | 1970-11-10 | Samuel Young | Combination pillow and crash helmet |
| FR2047874A6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-06-10 | 1971-03-19 | Nouvel Lucien | |
| US3723352A (en) | 1971-01-25 | 1973-03-27 | Air Prod & Chem | Supported silver catalysts |
| US3698392A (en) | 1971-04-21 | 1972-10-17 | Kewanee Oil Co | Topical dressing |
| US3763900A (en) | 1971-09-10 | 1973-10-09 | Milchwirlschaftliche Forschung | Process for sterilizing and filling aerosol containers |
| US3979335A (en) | 1974-12-27 | 1976-09-07 | Georgy Anatolievich Golovko | Process for the preparation of synthetic zeolites |
| JPS5792574A (en) | 1980-11-28 | 1982-06-09 | Nippon Denso Co | Manufacture of cordierite ceramics |
| US4379143A (en) | 1980-12-05 | 1983-04-05 | Pq Corporation | Topical liquid or ointment |
| US4374044A (en) | 1981-01-19 | 1983-02-15 | General Motors Corporation | Cordierite bead catalyst support and method of preparation |
| US4460642A (en) | 1981-06-26 | 1984-07-17 | Minnesota Mining And Manufacturing Company | Water-swellable composite sheet of microfibers of PTFE and hydrophilic absorptive particles |
| US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
| JPS58206751A (ja) | 1982-05-26 | 1983-12-02 | 日石三菱株式会社 | 創傷被覆材 |
| JPS5937956A (ja) | 1982-08-24 | 1984-03-01 | カネボウ株式会社 | 粒子充填繊維構造物 |
| JPS5962050A (ja) | 1982-09-30 | 1984-04-09 | 日本バイリ−ン株式会社 | 皮膚貼付剤 |
| JPS5962050U (ja) | 1982-10-20 | 1984-04-23 | ナイルス部品株式会社 | リトラクタブルヘツドランプ制御装置 |
| JPS59133235A (ja) | 1983-01-21 | 1984-07-31 | Kanebo Ltd | 殺菌性ポリマー組成物及びその製造法 |
| US4828832A (en) | 1983-09-07 | 1989-05-09 | Laboratorios Biochemie De Mexico | Method of manufacturing a composition for treating skin lesions |
| US4514510A (en) | 1983-09-08 | 1985-04-30 | American Colloid Company | Hydrogen enriched water swellable clay having reduced acid demand and stable at low pH |
| NZ209534A (en) | 1983-09-30 | 1987-01-23 | Surgikos Inc | Antimicrobial fabric for surgical drape |
| US4822349A (en) | 1984-04-25 | 1989-04-18 | Hursey Francis X | Method of treating wounds |
| US4748978A (en) | 1984-09-27 | 1988-06-07 | Kamp Herman F | Therapeutic dressing having mineral components |
| DK158066C (da) | 1984-11-21 | 1990-08-20 | Moelnlycke Ab | Fikseringsbind |
| JPH0245040Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-11-21 | 1990-11-29 | ||
| JPS61145120A (ja) | 1984-12-20 | 1986-07-02 | Sofuto Shirika Kk | 外傷患部の化膿防止剤 |
| US4626550A (en) | 1985-01-14 | 1986-12-02 | Pq Corporation | Zeolite for personal care products |
| JPS61145120U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1985-02-28 | 1986-09-08 | ||
| JPS61240963A (ja) | 1985-04-18 | 1986-10-27 | ユニチカ株式会社 | 創傷被覆保護材 |
| US4631845A (en) | 1985-05-17 | 1986-12-30 | Intermec Corporation | Luggage tag |
| GB2175889A (en) | 1985-05-23 | 1986-12-10 | Nat Res Dev | Clay films and applications |
| US4717735A (en) | 1986-04-10 | 1988-01-05 | European Body Wrap, Inc. | Composition for body wrap |
| US5599578A (en) | 1986-04-30 | 1997-02-04 | Butland; Charles L. | Technique for labeling an object for its identification and/or verification |
| US4728323A (en) | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
| US4938958A (en) | 1986-12-05 | 1990-07-03 | Shinagawa Fuel Co., Ltd. | Antibiotic zeolite |
| JPH0618899B2 (ja) | 1987-06-30 | 1994-03-16 | 品川燃料株式会社 | 抗菌性ゼオライト含有フィルム |
| JP2532515B2 (ja) | 1987-10-08 | 1996-09-11 | 水澤化学工業株式会社 | 血液凝集凝固剤 |
| JPH0196558U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1987-12-18 | 1989-06-27 | ||
| US4828081A (en) | 1988-03-04 | 1989-05-09 | Samsonite Corporation | Luggage identification system |
| JPH0245040A (ja) | 1988-08-03 | 1990-02-15 | Terumo Corp | 減圧採血管 |
| US4956350A (en) | 1988-08-18 | 1990-09-11 | Minnesota Mining And Manufacturing Company | Wound filling compositions |
| US5140949A (en) | 1989-09-19 | 1992-08-25 | Mobil Oil Corporation | Zeolite-clay composition and uses thereof |
| US5271943A (en) | 1989-10-27 | 1993-12-21 | Scott Health Care | Wound gel compositions containing sodium chloride and method of using them |
| NO171069C (no) | 1990-05-29 | 1993-01-20 | Protan Biopolymer As | Kovalent tverrbundne, sterkt svellende alkalimetall- og ammonium-alginatgeler, samt fremgangsmaate for fremstilling derav |
| JP2777279B2 (ja) | 1990-10-08 | 1998-07-16 | 工業技術院長 | 創傷被覆材及びその製造方法 |
| US5146932A (en) | 1990-11-01 | 1992-09-15 | Mccabe Francis J | Elastic counterpressure garment |
| GB9109367D0 (en) | 1991-05-01 | 1991-06-26 | Merck Sharp & Dohme | Surgical dressing |
| US5575995A (en) | 1991-08-15 | 1996-11-19 | Giovanoni; Richard L. | Ferric subsulfate gel and methods of using same |
| GB2259858A (en) | 1991-08-21 | 1993-03-31 | Glanmor Thomas Williams | Odour adsorbing means |
| GB9212303D0 (en) | 1992-06-10 | 1992-07-22 | Johnson & Johnson Medical Ltd | Absorbent products |
| US5474545A (en) | 1992-12-07 | 1995-12-12 | Chikazawa; Osamu | Diaper and/or sanitary napkin |
| GB9218749D0 (en) * | 1992-09-04 | 1992-10-21 | Courtaulds Plc | Alginate gels |
| DE4322956C2 (de) | 1993-07-09 | 1995-12-21 | Haack Karl Werner An | Folie aus Chitosan zur Wundversiegelung |
| US5725551A (en) | 1993-07-26 | 1998-03-10 | Myers; Gene | Method and apparatus for arteriotomy closure |
| US5486195A (en) | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
| GB9317180D0 (en) | 1993-08-18 | 1993-10-06 | Unilever Plc | Granular detergent compositions containing zeolite and process for their preparation |
| DE69433939T2 (de) | 1993-11-03 | 2005-08-11 | Clarion Pharmaceuticals, Inc., Madison | Hämostatisches pflaster |
| US5502042A (en) | 1994-07-22 | 1996-03-26 | United States Surgical Corporation | Methods and compositions for treating wounds |
| JPH0877746A (ja) | 1994-08-31 | 1996-03-22 | Sony Corp | 記録媒体収納カセット及びカセット保管用ケース、及びこれらに貼付けられるラベル |
| DE69534647T2 (de) | 1994-09-19 | 2006-07-27 | Sekisui Kagaku Kogyo K.K. | Behälter und träger für die blutuntersuchung enthaltend einen blutkomponenten adhäsions-inhibitor |
| WO1996016562A1 (en) | 1994-11-28 | 1996-06-06 | Langley John D | A breathable non-woven composite fabric |
| US5826543A (en) | 1995-01-20 | 1998-10-27 | Ralston Purina Company | Clumpable animal litter containing a dust reducing agent |
| US5538500A (en) | 1995-02-08 | 1996-07-23 | Peterson; Donald A. | Postoperative wound dressing |
| US5801116A (en) | 1995-04-07 | 1998-09-01 | Rhodia Inc. | Process for producing polysaccharides and their use as absorbent materials |
| FR2732585B1 (fr) | 1995-04-10 | 1997-10-17 | Garconnet Michel | Emballage perdu compact pour pansement de premiere urgence |
| US5578022A (en) | 1995-04-12 | 1996-11-26 | Scherson; Daniel A. | Oxygen producing bandage and method |
| US5788682A (en) | 1995-04-28 | 1998-08-04 | Maget; Henri J.R. | Apparatus and method for controlling oxygen concentration in the vicinity of a wound |
| GB9510226D0 (en) | 1995-05-20 | 1995-07-19 | Smith & Nephew | Sterilisable cream or paste product for topical application |
| DE69632401T2 (de) | 1995-06-07 | 2005-05-19 | Imarx Pharmaceutical Corp., Tucson | Neue zielgerichtete mittel zur diagnostischen und therapeutischen verwendung |
| AUPN851996A0 (en) | 1996-03-07 | 1996-03-28 | John Patrick Gray | Improvements in wound care management |
| US5696101A (en) | 1996-04-16 | 1997-12-09 | Eastman Chemical Company | Oxidized cellulose and vitamin E blend for topical hemostatic applications |
| US8696362B2 (en) | 1996-05-08 | 2014-04-15 | Gaumard Scientific Company, Inc. | Interactive education system for teaching patient care |
| US5964239A (en) | 1996-05-23 | 1999-10-12 | Hewlett-Packard Company | Housing assembly for micromachined fluid handling structure |
| GB2314842B (en) | 1996-06-28 | 2001-01-17 | Johnson & Johnson Medical | Collagen-oxidized regenerated cellulose complexes |
| US5891074A (en) | 1996-08-22 | 1999-04-06 | Avitar, Inc. | Pressure wound dressing |
| DE69729412T2 (de) | 1996-08-27 | 2005-06-16 | Rengo Co., Ltd. | Verbundmaterial aus einem hydrophilen, makromolekularen Substrat und anorganischen, porösen Kristallen |
| US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
| USD386002S (en) | 1996-10-01 | 1997-11-11 | Hinkle Gerald F | Combined pouch for first aid safety kit with instruction card |
| US8323305B2 (en) | 1997-02-11 | 2012-12-04 | Cardiva Medical, Inc. | Expansile device for use in blood vessels and tracts in the body and method |
| US6037280A (en) | 1997-03-21 | 2000-03-14 | Koala Konnection | Ultraviolet ray (UV) blocking textile containing particles |
| JPH10298824A (ja) | 1997-04-22 | 1998-11-10 | Chisso Corp | 繊維およびそれを用いた繊維成形体 |
| US5941897A (en) | 1997-05-09 | 1999-08-24 | Myers; Gene E. | Energy activated fibrin plug |
| JPH10337302A (ja) | 1997-06-06 | 1998-12-22 | Unitika Ltd | 鼓膜欠損閉鎖促進材及びその製造方法 |
| GB2326827B (en) | 1997-06-30 | 2002-02-20 | Johnson & Johnson Medical | Use of molecular sieves to promote wound healing |
| JPH1171228A (ja) | 1997-07-04 | 1999-03-16 | Shiseido Co Ltd | 油中水型乳化組成物 |
| JP3311650B2 (ja) | 1997-08-19 | 2002-08-05 | 日本碍子株式会社 | コージェライト質セラミックハニカム構造体の製造方法 |
| AU9400798A (en) | 1997-09-18 | 1999-04-05 | University Of Pittsburgh | Icam-1 selective echogenic microbubbles |
| US6159232A (en) | 1997-12-16 | 2000-12-12 | Closys Corporation | Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
| JPH11178912A (ja) | 1997-12-22 | 1999-07-06 | Kyocera Corp | 生体補綴部材 |
| US6372333B1 (en) | 1998-02-25 | 2002-04-16 | Rengo Co., Ltd. | Composition containing inorganic porous crystals-hydrophilic macromolecule composite and product made therefrom |
| WO1999045777A1 (en) | 1998-03-10 | 1999-09-16 | The Children's Hospital Of Philadelphia | Compositions and methods for treatment of asthma |
| US7018392B2 (en) | 1998-04-08 | 2006-03-28 | Arthrocare Corporation | Hemostatic system for body cavities |
| US6086970A (en) | 1998-04-28 | 2000-07-11 | Scimed Life Systems, Inc. | Lubricious surface extruded tubular members for medical devices |
| JPH11332909A (ja) | 1998-05-22 | 1999-12-07 | Frontier:Kk | 含塩溶液吸収用の吸収体 |
| US6123925A (en) | 1998-07-27 | 2000-09-26 | Healthshield Technologies L.L.C. | Antibiotic toothpaste |
| RU2176822C2 (ru) | 1998-07-27 | 2001-12-10 | Лутаенко Вячеслав Федорович | Тренажер для обучения приемам помощи человеку при неотложных состояниях |
| CN1181809C (zh) | 1998-09-25 | 2004-12-29 | 花王株式会社 | 口腔用组合物 |
| US20020197302A1 (en) | 1998-11-12 | 2002-12-26 | Cochrum Kent C. | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| DE69930297T2 (de) | 1998-11-24 | 2006-11-30 | Johnson & Johnson Consumer Companies, Inc. | Beschichtung auf wundverbänden und bandagen als träger für einen wirkstoff |
| JP4236751B2 (ja) | 1999-01-27 | 2009-03-11 | 日東電工株式会社 | 医療用粘着テープ若しくはシート、並びに救急絆創膏 |
| US6060461A (en) | 1999-02-08 | 2000-05-09 | Drake; James Franklin | Topically applied clotting material |
| CA2372384C (en) | 1999-04-29 | 2009-04-07 | Usbiomaterials Corporation | Anti-inflammatory bioactive glass particulates |
| US6203512B1 (en) | 1999-06-28 | 2001-03-20 | The Procter & Gamble Company | Method for opening a packaging device and retrieving an interlabial absorbent article placed therein |
| JP3423261B2 (ja) | 1999-09-29 | 2003-07-07 | 三洋電機株式会社 | 表示装置 |
| US6450537B2 (en) | 2000-01-24 | 2002-09-17 | Polaroid Corporation | Self-service postage stamp assemblage |
| KR100721752B1 (ko) | 2000-01-24 | 2007-05-25 | 쿠라레 메디카루 가부시키가이샤 | 수팽윤성 고분자 겔 및 그 제조법 |
| US6187347B1 (en) | 2000-02-09 | 2001-02-13 | Ecosafe, Llc. | Composition for arresting the flow of blood and method |
| BR0110670A (pt) | 2000-04-28 | 2005-05-24 | Biolife Llc | Agente hemostático e veìculo de liberação para o mesmo |
| US20020141964A1 (en) | 2001-01-19 | 2002-10-03 | Patterson James A. | Composition for arresting the flow of blood and method |
| US6592888B1 (en) | 2000-05-31 | 2003-07-15 | Jentec, Inc. | Composition for wound dressings safely using metallic compounds to produce anti-microbial properties |
| WO2001097826A2 (en) | 2000-06-16 | 2001-12-27 | University Of Medicine And Dentistry Of New Jersey | Hemostatic compositions, devices and methods |
| US6523778B2 (en) | 2000-06-29 | 2003-02-25 | The Night Fun Co., Llc | Illuminated emergency signaling device and flying balloon |
| US6685227B2 (en) | 2000-07-14 | 2004-02-03 | Safer Sleep Limited | Label, a label system and method |
| IL138099A0 (en) | 2000-08-25 | 2001-10-31 | Naimer Richard | Bandage |
| US20040013715A1 (en) | 2001-09-12 | 2004-01-22 | Gary Wnek | Treatment for high pressure bleeding |
| KR100909233B1 (ko) | 2000-09-14 | 2009-07-23 | 히사미쓰 세이야꾸 가부시키가이샤 | 창상 피복용 제제 |
| ATE460146T1 (de) | 2000-09-15 | 2010-03-15 | Bruder Healthcare Co | Wund- und behandlungskompresse und verband |
| WO2002030479A1 (en) | 2000-10-13 | 2002-04-18 | On Site Gas Systems, Inc. | Bandage using molecular sieves |
| ATE312579T1 (de) | 2001-01-31 | 2005-12-15 | Missak Kechichian | Absorbierendes produkt |
| CN1516595A (zh) | 2001-03-19 | 2004-07-28 | Iomai公司 | 用于经皮免疫的贴剂 |
| US20040166172A1 (en) | 2001-03-27 | 2004-08-26 | Coni Rosati | Bioctive tissue abrasives |
| US6481134B1 (en) | 2001-04-02 | 2002-11-19 | Alicia Aledo | Tag for attaching to a garment having an attribute and identifying the attribute to a person unable to visually identify the attribute |
| US6622856B2 (en) | 2001-04-25 | 2003-09-23 | Johnson & Johnson Consumer Companies, Inc. | Relief kit |
| EP1397167B1 (en) | 2001-05-09 | 2010-02-24 | Biointeractions Ltd. | Wound closure system and methods |
| JP4853887B2 (ja) | 2001-05-09 | 2012-01-11 | 日東電工株式会社 | 貼付材及び絆創膏並びに救急絆創膏 |
| US7371403B2 (en) | 2002-06-14 | 2008-05-13 | Providence Health System-Oregon | Wound dressing and method for controlling severe, life-threatening bleeding |
| US20050147656A1 (en) | 2001-06-14 | 2005-07-07 | Hemcon, Inc. | Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
| IL159156A0 (en) | 2001-06-22 | 2004-06-01 | Millard Marsden Mershon | A gel forming composition containing a polyacrylic acid |
| US20030073249A1 (en) | 2001-07-07 | 2003-04-17 | Lee Duen | Allergen detection chip |
| US7429252B2 (en) | 2001-12-12 | 2008-09-30 | Ogenix Corporation | Oxygen producing device for woundcare |
| US20050119112A1 (en) | 2002-01-22 | 2005-06-02 | Zeochem, Llc | Process for production of molecular sieve adsorbent blends |
| US7544177B2 (en) | 2002-01-24 | 2009-06-09 | The Regents Of The University Of California | Aerosol device to deliver bioactive agent |
| WO2003065877A2 (en) | 2002-02-04 | 2003-08-14 | Damage Control Surgical Technologies, Inc. | Method and apparatus for improved hemostasis and damage control operations |
| JP4354280B2 (ja) | 2002-03-01 | 2009-10-28 | イミューノメディクス、インコーポレイテッド | Ｒｓ７抗体 |
| US20030175333A1 (en) | 2002-03-06 | 2003-09-18 | Adi Shefer | Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin |
| JP2003305079A (ja) | 2002-04-17 | 2003-10-28 | Sekisui Film Kk | 粘着テープ |
| US20030199922A1 (en) | 2002-04-22 | 2003-10-23 | Buckman James S. | Pneumatic pressure bandage for medical applications |
| US20030212357A1 (en) | 2002-05-10 | 2003-11-13 | Pace Edgar Alan | Method and apparatus for treating wounds with oxygen and reduced pressure |
| US20060193905A1 (en) | 2002-05-14 | 2006-08-31 | University Of Louisville Research Foundation, Inc. | Direct cellular energy delivery system |
| WO2003103475A2 (en) | 2002-06-07 | 2003-12-18 | Dyax Corp. | Prevention and reduction of blood loss |
| US8269058B2 (en) | 2002-06-14 | 2012-09-18 | Hemcon Medical Technologies, Inc. | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
| US20050137512A1 (en) | 2003-12-23 | 2005-06-23 | Campbell Todd D. | Wound dressing and method for controlling severe, life-threatening bleeding |
| US20040101546A1 (en) | 2002-11-26 | 2004-05-27 | Gorman Anne Jessica | Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents |
| US7279177B2 (en) | 2002-06-28 | 2007-10-09 | Ethicon, Inc. | Hemostatic wound dressings and methods of making same |
| GB2393120A (en) | 2002-09-18 | 2004-03-24 | Johnson & Johnson Medical Ltd | Compositions for wound treatment |
| JP3794365B2 (ja) | 2002-10-04 | 2006-07-05 | 憲司 中村 | 保温消臭殺菌用配合剤および保温消臭殺菌用材 |
| US6745720B2 (en) | 2002-10-29 | 2004-06-08 | Cycle Group Limited Of Delaware | Clumping animal litter and method of making same |
| US6890177B2 (en) | 2002-12-02 | 2005-05-10 | Centrix, Inc. | Method and device for the retraction and hemostasis of tissue during crown and bridge procedures |
| US6701649B1 (en) | 2002-12-12 | 2004-03-09 | Gunter Brosi | Combat identification marker |
| US7060795B2 (en) | 2002-12-19 | 2006-06-13 | Kimberly-Clark Worldwide, Inc. | Wound care compositions |
| WO2004056383A1 (en) | 2002-12-20 | 2004-07-08 | Council Of Scientific And Industrial Research | Herbal composition for cuts, burns and wounds |
| AU2003301008B2 (en) | 2002-12-20 | 2006-09-07 | The Procter & Gamble Company | Tufted fibrous web |
| US7994078B2 (en) | 2002-12-23 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | High strength nonwoven web from a biodegradable aliphatic polyester |
| JP3975944B2 (ja) | 2003-02-27 | 2007-09-12 | 住友電気工業株式会社 | 半導体あるいは液晶製造装置用保持体およびそれを搭載した半導体あるいは液晶製造装置 |
| US7322976B2 (en) | 2003-03-04 | 2008-01-29 | Cardiva Medical, Inc. | Apparatus and methods for closing vascular penetrations |
| JP4589608B2 (ja) | 2003-06-24 | 2010-12-01 | ニプロパッチ株式会社 | 感圧性粘着テープ |
| KR100544123B1 (ko) | 2003-07-29 | 2006-01-23 | 삼성에스디아이 주식회사 | 평판표시장치 |
| EP2216342B1 (en) | 2003-07-31 | 2015-04-22 | Immunomedics, Inc. | Anti-CD19 antibodies |
| AU2004264981B2 (en) | 2003-08-14 | 2011-05-19 | Loma Linda University Medical Center | Vascular wound closure device |
| US20050143689A1 (en) | 2003-08-17 | 2005-06-30 | Ramsey Maynard Iii | Internal compression tourniquet catheter system and method for wound track navigation and hemorrhage control |
| US7125821B2 (en) | 2003-09-05 | 2006-10-24 | Exxonmobil Chemical Patents Inc. | Low metal content catalyst compositions and processes for making and using same |
| WO2005027808A1 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Calcium zeolite hemostatic agent |
| WO2005027834A2 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Partially hydrated hemostatic agent |
| CA2443059A1 (en) | 2003-09-29 | 2005-03-29 | Le Groupe Lysac Inc. | Polysaccharide-clay superabsorbent nanocomposites |
| EP1677846B1 (en) | 2003-10-22 | 2014-08-20 | Encelle, Inc. | Bioactive hydrogel compositions for regenerating connective tissue |
| AU2003284808B2 (en) | 2003-11-14 | 2009-01-22 | Catalyst Biosciences, Inc. | The derivatives of pyridone and the use of them |
| EP1727569A1 (en) | 2004-03-11 | 2006-12-06 | Medtrade Products Ltd. | Compositions of alpha and beta chitosan and methods of preparing them |
| EP1735042B1 (en) | 2004-03-19 | 2011-11-23 | Abbott Laboratories | Multiple drug delivery from a balloon and a prosthesis |
| GB0407502D0 (en) | 2004-04-02 | 2004-05-05 | Inotec Amd Ltd | Hyperbaric dressing |
| US9017374B2 (en) | 2004-04-09 | 2015-04-28 | Cardiva Medical, Inc. | Device and method for sealing blood vessels |
| US7993366B2 (en) | 2004-05-27 | 2011-08-09 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
| US7572274B2 (en) | 2004-05-27 | 2009-08-11 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
| US20080154303A1 (en) | 2006-12-21 | 2008-06-26 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
| US20050226911A1 (en) | 2004-04-13 | 2005-10-13 | Bringley Joseph F | Article for inhibiting microbial growth in physiological fluids |
| US20050248270A1 (en) | 2004-05-05 | 2005-11-10 | Eastman Kodak Company | Encapsulating OLED devices |
| US20050249899A1 (en) | 2004-05-06 | 2005-11-10 | Bonutti Peter M | Biodegradable packaging material |
| GB2415382A (en) | 2004-06-21 | 2005-12-28 | Johnson & Johnson Medical Ltd | Wound dressings for vacuum therapy |
| US8916208B2 (en) | 2004-06-24 | 2014-12-23 | California Institute Of Technology | Aluminophosphate-based materials for the treatment of wounds |
| US7326043B2 (en) | 2004-06-29 | 2008-02-05 | Cornell Research Foundation, Inc. | Apparatus and method for elevated temperature electrospinning |
| US20060008505A1 (en) | 2004-07-08 | 2006-01-12 | Brandon Gerard J | Product |
| WO2006012541A2 (en) | 2004-07-22 | 2006-02-02 | Henry Eisenson | Compositions and methods for treating excessive bleeding |
| US20060078628A1 (en) | 2004-10-09 | 2006-04-13 | Karl Koman | Wound treating agent |
| US20060116635A1 (en) | 2004-11-29 | 2006-06-01 | Med Enclosure L.L.C. | Arterial closure device |
| US20060121101A1 (en) | 2004-12-08 | 2006-06-08 | Ladizinsky Daniel A | Method for oxygen treatment of intact skin |
| US8535709B2 (en) | 2004-12-13 | 2013-09-17 | Southeastern Medical Technologies, Llc | Agents for controlling biological fluids and methods of use thereof |
| US20060127437A1 (en) | 2004-12-13 | 2006-06-15 | Misty Anderson Kennedy | Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids |
| US20060141060A1 (en) | 2004-12-27 | 2006-06-29 | Z-Medica, Llc | Molecular sieve materials having increased particle size for the formation of blood clots |
| US20060178609A1 (en) | 2005-02-09 | 2006-08-10 | Z-Medica, Llc | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
| AU2006214371A1 (en) | 2005-02-15 | 2006-08-24 | Virginia Commonwealth University | Mineral technologies (MT) for acute hemostasis and for the treatment of acute wounds and chronic ulcers |
| GB0504445D0 (en) | 2005-03-03 | 2005-04-06 | Univ Cambridge Tech | Oxygen generation apparatus and method |
| US20060211965A1 (en) | 2005-03-16 | 2006-09-21 | Z-Medica, Llc | Device for the delivery of blood clotting materials to a wound site |
| US20060211971A1 (en) | 2005-03-16 | 2006-09-21 | Z-Medica, Llc | Pillow for the delivery of blood clotting materials to a wound site |
| US9326995B2 (en) | 2005-04-04 | 2016-05-03 | The Regents Of The University Of California | Oxides for wound healing and body repair |
| CN101151039A (zh) | 2005-04-04 | 2008-03-26 | 加利福尼亚大学董事会 | 用于止血调节和伤口愈合治疗的无机材料 |
| US20060282046A1 (en) | 2005-04-13 | 2006-12-14 | Horn Jeffrey L | Device and method for subcutaneous delivery of blood clotting agent |
| EP1714642A1 (en) | 2005-04-18 | 2006-10-25 | Bracco Research S.A. | Pharmaceutical composition comprising gas-filled microcapsules for ultrasound mediated delivery |
| US20070004995A1 (en) | 2005-06-30 | 2007-01-04 | Horn Jeffrey L | Swab device and kit for the delivery of blood clotting materials to a wound site |
| US7438705B2 (en) | 2005-07-14 | 2008-10-21 | Boehringer Technologies, L.P. | System for treating a wound with suction and method detecting loss of suction |
| US8063264B2 (en) | 2005-08-26 | 2011-11-22 | Michael Spearman | Hemostatic media |
| JP2009507925A (ja) | 2005-09-13 | 2009-02-26 | エラン ファーマ インターナショナル リミテッド | ナノ粒子タダラフィル製剤 |
| US20070104768A1 (en) | 2005-11-07 | 2007-05-10 | Z-Medica Corporation | Devices for the delivery of molecular sieve materials for the formation of blood clots |
| US20090076475A1 (en) | 2005-11-09 | 2009-03-19 | Oxysure Systems Inc. | Method and apparatus for delivering therapeutic oxygen treatments |
| US9179897B2 (en) | 2005-12-13 | 2015-11-10 | Cardiva Medical, Inc. | Vascular closure devices and methods providing hemostatic enhancement |
| US8911472B2 (en) | 2005-12-13 | 2014-12-16 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
| US7691127B2 (en) | 2005-12-13 | 2010-04-06 | Cardiva Medical, Inc. | Drug eluting vascular closure devices and methods |
| US20100168767A1 (en) | 2008-06-30 | 2010-07-01 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
| US20070142783A1 (en) | 2005-12-16 | 2007-06-21 | Huey Raymond J | Devices and methods for promoting the formation of blood clots at dialysis access sites |
| US20070154510A1 (en) | 2005-12-30 | 2007-07-05 | Wilcher Steve A | Adsorbent-Containing Hemostatic Devices |
| US20070154509A1 (en) | 2005-12-30 | 2007-07-05 | Wilcher Steve A | Adsorbent-Containing Hemostatic Devices |
| US9474652B2 (en) | 2006-01-09 | 2016-10-25 | Jack Mentkow | Hemostatic agent delivery system |
| US8409629B2 (en) | 2006-01-09 | 2013-04-02 | Jack Mentkow | Hemostatic agent composition and method of delivery |
| US8609129B2 (en) | 2006-01-09 | 2013-12-17 | Jack Mentkow | Hemostatic agent composition, delivery system and method |
| US8277837B2 (en) | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
| US20070167971A1 (en) | 2006-01-17 | 2007-07-19 | Raymond Huey | Devices and methods for promoting the formation of blood clots in esophageal varices |
| FR2899479B1 (fr) | 2006-04-10 | 2009-07-24 | Agelys Lab | Composition cicatrisante |
| US20090011394A1 (en) | 2006-04-14 | 2009-01-08 | Simquest Llc | Limb hemorrhage trauma simulator |
| US8938898B2 (en) | 2006-04-27 | 2015-01-27 | Z-Medica, Llc | Devices for the identification of medical products |
| FR2900824A1 (fr) | 2006-05-10 | 2007-11-16 | Prod Dentaires Pierre Rolland | Pate destinee a arreter les saignements, ses utilisations, et seringue la contenant |
| US7968114B2 (en) | 2006-05-26 | 2011-06-28 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US8202532B2 (en) | 2006-05-26 | 2012-06-19 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US20070276308A1 (en) * | 2006-05-26 | 2007-11-29 | Huey Raymond J | Hemostatic agents and devices for the delivery thereof |
| EP2343053A1 (en) | 2006-05-30 | 2011-07-13 | Elan Pharma International Limited | Nanoparticulate posaconazole formulations |
| US20080027365A1 (en) | 2006-06-01 | 2008-01-31 | Huey Raymond J | Hemostatic device with oxidized cellulose pad |
| CN1970090B (zh) | 2006-09-14 | 2015-11-25 | 华东理工大学 | 纳米介孔硅基干凝胶止血材料及其制备方法和应用 |
| US9198995B2 (en) | 2006-09-20 | 2015-12-01 | Ore-Medix Llc | Conformable structured therapeutic dressing |
| US20080085300A1 (en) * | 2006-10-06 | 2008-04-10 | Z-Medica Corporation | Hemostatic compositions and method of manufacture |
| US20080097271A1 (en) | 2006-10-20 | 2008-04-24 | Z-Medica Corporation | Devices and methods for the delivery of hemostatic agents to bleeding wounds |
| US20080125686A1 (en) | 2006-11-29 | 2008-05-29 | Denny Lo | Heat mitigating hemostatic agent |
| US20080145455A1 (en) | 2006-12-13 | 2008-06-19 | Bedard Robert L | Combination of Inorganic Hemostatic Agents with Other Hemostatic Agents |
| US20100184348A1 (en) | 2006-12-20 | 2010-07-22 | Imerys Pigments, Inc. | Spunlaid Fibers Comprising Coated Calcium Carbonate, Processes For Their Production, and Nonwoven Products |
| WO2008127497A2 (en) | 2007-02-21 | 2008-10-23 | The Regents Of The University Of California | Hemostatic compositions and methods of use |
| US20080206134A1 (en) | 2007-02-22 | 2008-08-28 | Denny Lo | Radio-opaque hemostatic agents and devices and methods for the delivery thereof |
| US20080254147A1 (en) | 2007-04-13 | 2008-10-16 | Z-Medica Corporation | Method of providing hemostasis in anti-coagulated blood |
| TW200906421A (en) | 2007-04-13 | 2009-02-16 | Raymond J Huey | Method of providing hemostasis in anti-coagulated blood |
| CN101104080B (zh) | 2007-04-24 | 2011-06-22 | 深圳市鸿华投资有限公司 | 沸石止血敷料及其制备方法和用途 |
| US20080319476A1 (en) | 2007-05-22 | 2008-12-25 | Ward Kevin R | Hemostatic mineral compositions and uses thereof |
| US20080317831A1 (en) | 2007-06-21 | 2008-12-25 | Denny Lo | Hemostatic sponge and method of making the same |
| WO2009021047A2 (en) | 2007-08-06 | 2009-02-12 | Ohio Medical Corporation | Wound treatment system and suction regulator for use therewith |
| US20090047366A1 (en) | 2007-08-15 | 2009-02-19 | Bedard Robert L | Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants |
| US20090053288A1 (en) | 2007-08-20 | 2009-02-26 | Eskridge Jr E Stan | Hemostatic woven fabric |
| US20090162406A1 (en) | 2007-09-05 | 2009-06-25 | Z-Medica Corporation | Wound healing with zeolite-based hemostatic devices |
| US8287506B2 (en) | 2007-10-26 | 2012-10-16 | Electrochemical Oxygen Concepts, Inc. | Apparatus and methods for controlling tissue oxygenation for wound healing and promoting tissue viability |
| US8883194B2 (en) | 2007-11-09 | 2014-11-11 | Honeywell International, Inc. | Adsorbent-containing hemostatic devices |
| US8319002B2 (en) | 2007-12-06 | 2012-11-27 | Nanosys, Inc. | Nanostructure-enhanced platelet binding and hemostatic structures |
| US20110059287A1 (en) | 2008-01-21 | 2011-03-10 | Imerys Pigments, Inc. | Fibers comprising at least one filler, processes for their production, and uses thereof |
| US20100035045A1 (en) | 2008-01-21 | 2010-02-11 | Imerys Pigments, Inc. | Fibers comprising at least one filler and processes for their production |
| US8563799B2 (en) | 2008-02-25 | 2013-10-22 | Teikoku Seiyaku Co., Ltd. | Wound-covering hydrogel material |
| CN102014973A (zh) | 2008-02-29 | 2011-04-13 | 弗罗桑医疗设备公司 | 用于促进止血和/或伤口愈合的装置 |
| MX338212B (es) | 2008-04-11 | 2016-04-07 | Univ Virginia Commonwealth | Fibras de dextran electrohiladas y dispositivos formados de las mismas. |
| GB2461019B (en) * | 2008-04-25 | 2013-06-05 | Medtrade Products Ltd | Haemostatic material |
| EP2279012A4 (en) | 2008-05-02 | 2013-05-29 | Providence Health Sys Oregon | WOUND ASSOCIATIONS AND PROCEDURES |
| JP2011519679A (ja) | 2008-05-06 | 2011-07-14 | ウィルソン−クック・メディカル・インコーポレーテッド | 治療薬を送達するための器具及び方法 |
| US20100080791A1 (en) * | 2008-09-26 | 2010-04-01 | Rousseau Robert A | Composition and Method For Treating Tissue Defects |
| US8780054B2 (en) | 2008-09-26 | 2014-07-15 | Lg Electronics Inc. | Mobile terminal and control method thereof |
| EP2172167A1 (en) | 2008-10-02 | 2010-04-07 | 3M Innovative Properties Company | Dental retraction device and process of its production |
| GB2477257B (en) | 2008-12-18 | 2014-06-18 | Fmc Corp | Peracetic acid oil-field biocide and method |
| JP5631332B2 (ja) | 2008-12-23 | 2014-11-26 | クック メディカル テクノロジーズ エルエルシーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ | 治療薬を収容及び送達するための器械及び方法 |
| US8118777B2 (en) | 2009-05-29 | 2012-02-21 | Cook Medical Technologies Llc | Systems and methods for delivering therapeutic agents |
| US9142144B2 (en) | 2009-06-16 | 2015-09-22 | Simquest Llc | Hemorrhage control simulator |
| US20110015565A1 (en) | 2009-07-15 | 2011-01-20 | Hursey Francis X | Gas dispenser with therapeutic agent |
| US9370347B2 (en) | 2010-02-10 | 2016-06-21 | Cardiva Medical, Inc. | Bilateral vessel closure |
| US20120004636A1 (en) | 2010-07-02 | 2012-01-05 | Denny Lo | Hemostatic fibrous material |
| US9029200B2 (en) * | 2010-07-15 | 2015-05-12 | Infineon Technologies Austria Ag | Method for manufacturing semiconductor devices having a metallisation layer |
| US8595429B2 (en) | 2010-08-24 | 2013-11-26 | Qualcomm Incorporated | Wide input/output memory with low density, low latency and high density, high latency blocks |
| US8858969B2 (en) | 2010-09-22 | 2014-10-14 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
| CN201920992U (zh) * | 2010-12-29 | 2011-08-10 | 稳健实业(深圳)有限公司 | 一种医用敷料 |
| US20130060279A1 (en) | 2011-09-02 | 2013-03-07 | Cardiva Medical, Inc. | Catheter with sealed hydratable hemostatic occlusion element |
| CN102274541A (zh) * | 2011-09-09 | 2011-12-14 | 天津禹王生物医药科技有限公司 | 一种止血材料 |
| IN2014DN11041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2012-06-22 | 2015-09-25 | Z Medica Llc | |
| KR20150058382A (ko) | 2012-09-21 | 2015-05-28 | 지-메디카 엘엘씨 | 출혈 제어 훈련을 제공하기 위한 시스템 및 방법 |
| US9867931B2 (en) | 2013-10-02 | 2018-01-16 | Cook Medical Technologies Llc | Therapeutic agents for delivery using a catheter and pressure source |
| US9502099B2 (en) | 2014-11-14 | 2016-11-22 | Cavium, Inc. | Managing skew in data signals with multiple modes |
| US10531868B2 (en) | 2017-12-01 | 2020-01-14 | Cardiva Medical, Inc. | Apparatus and methods for accessing and closing multiple penetrations on a blood vessel |
-
2013
- 2013-05-17 IN IN11041DEN2014 patent/IN2014DN11041A/en unknown
- 2013-05-17 CN CN201910769500.4A patent/CN110478518A/zh active Pending
- 2013-05-17 KR KR1020197002832A patent/KR102037150B1/ko active Active
- 2013-05-17 AU AU2013277643A patent/AU2013277643B2/en active Active
- 2013-05-17 KR KR1020167005352A patent/KR101945031B1/ko active Active
- 2013-05-17 PL PL13806931T patent/PL2863961T3/pl unknown
- 2013-05-17 EP EP18183513.3A patent/EP3412320A1/en active Pending
- 2013-05-17 MX MX2014015746A patent/MX336734B/es unknown
- 2013-05-17 WO PCT/US2013/041659 patent/WO2013191836A1/en active Application Filing
- 2013-05-17 CN CN201380033078.7A patent/CN104507507A/zh active Pending
- 2013-05-17 ES ES13806931.5T patent/ES2690826T3/es active Active
- 2013-05-17 KR KR1020147036526A patent/KR101600470B1/ko active Active
- 2013-05-17 DK DK13806931.5T patent/DK2863961T3/da active
- 2013-05-17 PT PT13806931T patent/PT2863961T/pt unknown
- 2013-05-17 SI SI201331241T patent/SI2863961T1/sl unknown
- 2013-05-17 LT LTEP13806931.5T patent/LT2863961T/lt unknown
- 2013-05-17 JP JP2015518410A patent/JP6001169B2/ja active Active
- 2013-05-17 RU RU2015101029/15A patent/RU2599033C2/ru active
- 2013-05-17 CA CA2876850A patent/CA2876850C/en active Active
- 2013-05-17 KR KR1020197031099A patent/KR102189877B1/ko active Active
- 2013-05-17 KR KR1020207035071A patent/KR102375103B1/ko active Active
- 2013-05-17 CA CA3183404A patent/CA3183404A1/en active Pending
- 2013-05-17 MX MX2016001244A patent/MX376779B/es unknown
- 2013-05-17 HR HRP20181611TT patent/HRP20181611T1/hr unknown
- 2013-05-17 EP EP13806931.5A patent/EP2863961B1/en active Active
- 2013-05-17 BR BR112014031439A patent/BR112014031439A8/pt not_active Application Discontinuation
- 2013-06-19 US US13/922,115 patent/US9072806B2/en active Active
- 2013-06-20 TW TW102121830A patent/TWI539936B/zh active
-
2014
- 2014-12-11 IL IL236188A patent/IL236188A0/en active IP Right Grant
- 2014-12-17 MX MX2020011524A patent/MX2020011524A/es unknown
- 2014-12-17 MX MX2022013534A patent/MX2022013534A/es unknown
- 2014-12-23 CO CO14282346A patent/CO7240435A2/es unknown
-
2015
- 2015-05-22 US US14/720,142 patent/US9352066B2/en active Active
- 2015-10-22 AU AU2015246140A patent/AU2015246140B2/en active Active
- 2015-11-02 IL IL242411A patent/IL242411B/en active IP Right Grant
-
2016
- 2016-03-16 US US15/071,520 patent/US9603964B2/en active Active
- 2016-08-23 JP JP2016162508A patent/JP2016202969A/ja active Pending
-
2017
- 2017-02-10 US US15/429,935 patent/US10960100B2/en active Active
- 2017-02-20 AU AU2017201139A patent/AU2017201139B2/en active Active
-
2018
- 2018-09-20 JP JP2018175882A patent/JP6567748B2/ja active Active
-
2019
- 2019-01-11 HK HK19100449.6A patent/HK1258069A1/en unknown
- 2019-07-30 JP JP2019139834A patent/JP6888054B2/ja active Active
-
2021
- 2021-02-18 US US17/179,013 patent/US11559601B2/en active Active
- 2021-05-18 JP JP2021083844A patent/JP7321210B2/ja active Active
-
2023
- 2023-01-23 US US18/158,039 patent/US20230149592A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060141018A1 (en) * | 2001-12-31 | 2006-06-29 | Crosslink-D, Incorporated, A Delaware Corporation | Hemostatic compositions and methods for controlling bleeding |
| US20120130296A1 (en) * | 2006-05-26 | 2012-05-24 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US20110237994A1 (en) * | 2010-03-25 | 2011-09-29 | Combat Medical Systems, Llc | Void-filling wound dressing |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2721281C1 (ru) * | 2019-07-29 | 2020-05-18 | Общество с ограниченной ответственностью "Нанотехнологии и инновации" | Фармацевтическая композиция, обладающая антимикробной и противогрибковой активностью |
| RU2810165C1 (ru) * | 2020-03-02 | 2023-12-22 | Иннотерапи Инк. | Аппликационный гемостатический материал и способ его производства |
| RU2793065C1 (ru) * | 2023-02-03 | 2023-03-28 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Ручное автономное устройство двухкомпонентной биопечати для лечения раневых поверхностей и способ нанесения покрытия на раневую поверхность ручным автономным устройством |
| RU2827960C1 (ru) * | 2023-04-24 | 2024-10-04 | Общество с ограниченной ответственностью "Ангиолайн Ресерч" | Гемостатический раствор, гемостатическое изделие и способ его изготовления |
| RU225524U1 (ru) * | 2024-01-15 | 2024-04-23 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Ручное автономное устройство биопечати для лечения раневых поверхностей |
| RU233552U1 (ru) * | 2024-03-13 | 2025-04-24 | Общество с ограниченной ответственностью "Медицинские разработки" | Бинт на основе нетканого материала, обладающий гемостатическим действием |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7321210B2 (ja) | 止血デバイス | |
| HK40010696A (en) | Hemostatic devices | |
| HK1206650B (en) | Hemostatic devices |